Aclidinium + formoterol

Trade Name: 
Duaklir Genuair
Manufacturer/Distributor: 
AstraZeneca Canada Inc.
www.astrazeneca.ca
Classification: 
Bronchodilator combination - LAMA plus LABA
ATC Class: 
R03AL - Adrenergics with anticholinergics
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/04/02
Date Marketed in Canada (yyyy/mm/dd): 
2015/07/09
Presentation: 
Powder for Inhalation: aclidinium 400 mcg plus formoterol 12 mcg. DIN: 02439530
Comments: 
Combination of a long-acting muscarinic antagonist (LAMA) and a long-acting beta2-adrenergic agonist (LABA) for the long term maintenance bronchodilator treatment of patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.